Koninklijke DSM N.V.
KDSKF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $7,590 | $8,390 | $9,204 | $8,106 |
| % Growth | -9.5% | -8.8% | 13.5% | – |
| Cost of Goods Sold | $6,021 | $5,700 | $6,040 | $5,330 |
| Gross Profit | $1,569 | $2,690 | $3,164 | $2,776 |
| % Margin | 20.7% | 32.1% | 34.4% | 34.2% |
| R&D Expenses | $352 | $295 | $323 | $398 |
| G&A Expenses | $619 | $538 | $517 | $469 |
| SG&A Expenses | $1,670 | $1,773 | $1,787 | $1,618 |
| Sales & Mktg Exp. | $1,051 | $1,235 | $1,270 | $1,149 |
| Other Operating Expenses | -$4 | $7 | $0 | $0 |
| Operating Expenses | $2,018 | $2,046 | $2,139 | $2,100 |
| Operating Income | -$412 | $682 | $1,021 | $662 |
| % Margin | -5.4% | 8.1% | 11.1% | 8.2% |
| Other Income/Exp. Net | -$58 | -$88 | -$23 | -$67 |
| Pre-Tax Income | -$470 | $594 | $998 | $595 |
| Tax Expense | -$16 | $124 | $168 | $106 |
| Net Income | $2,318 | $1,700 | $1,676 | $506 |
| % Margin | 30.5% | 20.3% | 18.2% | 6.2% |
| EPS | 13.41 | 9.8 | 9.68 | 2.91 |
| % Growth | 36.8% | 1.2% | 232.6% | – |
| EPS Diluted | 13.38 | 9.77 | 9.63 | 2.89 |
| Weighted Avg Shares Out | 173 | 173 | 173 | 172 |
| Weighted Avg Shares Out Dil | 173 | 173 | 173 | 172 |
| Supplemental Information | – | – | – | – |
| Interest Income | $118 | $22 | $3 | $17 |
| Interest Expense | $141 | $130 | $110 | $98 |
| Depreciation & Amortization | $636 | $652 | $681 | $740 |
| EBITDA | $307 | $1,376 | $1,396 | $1,433 |
| % Margin | 4% | 16.4% | 15.2% | 17.7% |